News in the Life Sciences Industry

OSLO, Norway, June 10, 2020 /PRNewswire/ -- Photocure ASA (OSE: PHO) today announces the company's first sustainability report, which will be presented at the Annual General Meeting (AGM) at 17:00 CET. The AGM will be live streamed and Dan Schneider, President & Chief Executive Officer,... Read more ››

NORTH CHICAGO, Illinois and COPENHAGEN, Denmark, June 10, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Genmab A/S (Nasdaq: GMAB) announced today that AbbVie and Genmab have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab's early-stage investigational... Read more ››

LUND, Sweden, June 9, 2020 /PRNewswire/ -- On June 4(th), Immunovia announced a Directed Share Issue raising ~400 MSEK in capital, resulting in one of the largest fundraising for a non-US based diagnostics company. Proceeds from this Directed Share Issue will be used for the commercialization... Read more ››

SINGAPORE, June 9, 2020 /PRNewswire/ -- In response to the physical distancing orders to help reduce the effects of the coronavirus, Oticon has now expanded its eHealth solution so that hearing care professionals can also perform a digital first fit with Oticon RemoteCare for select patients.... Read more ››

SINGAPORE, June 9, 2020 /PRNewswire/ -- In response to the physical distancing orders to help reduce the effects of the coronavirus, Oticon has now expanded its eHealth solution so that hearing care professionals can also perform a digital first fit with Oticon RemoteCare for select patients.... Read more ››

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››